Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Publications
»
Ziagen (abacavir sulfate)
Your Selection
[x]
Document Type
: Direct Healthcare Professional Communication
[x]
Year
: 2000
[x] Remove All Filters
By Product
Human medicines (1)
By Audience / Stakeholder Group
Healthcare professionals (1)
Ziagen (abacavir sulfate) - Important Safety Information from GlaxoWellcome as approved by the Irish Medicines Board
21 January 2000
Tags:
Human medicines
Healthcare professionals
Direct Healthcare Professional Communication
2000
Please find attached Safety Communication from GlaxoWellcome in respect of Ziagen
« View Publications List
Provide Feedback
RSS Feeds
IMB Publications RSS Feed